News
VivoSim Labs
VIVS · NASDAQ
$0.1713+$0.0138 (+8.76%)TodayMarket closed ·
Prev close $0.1575
Latest news
- Press releaseGlobe Newswire
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
- Press releaseGlobe Newswire
VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
- NewsAvi Kapoor
Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseGlobe Newswire
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsLekha Gupta
Why Is VivoSim Labs Stock Falling Thursday?
- NewsAvi Kapoor
Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsLekha Gupta
Why Vivosim Labs Shares Are Rocketing on Wednesday?
- Press releaseGlobe Newswire
Three Biotechs Deliver Catalysts to Watch
- Press releaseGlobe Newswire
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
- NewsAvi Kapoor
Gold Tumbles Over 6%; Apple Posts Upbeat Earnings
- NewsAvi Kapoor
Dow Falls Over 100 Points; Verizon Earnings Top Views
- News
Market-Moving News for January 30th
- Press releaseGlobe Newswire
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
- Press releaseGlobe Newswire
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.